| Lomitapide | None | ||
| 5MG, 10MG, 20MG, 30MG, 40MG, 60MG, 2MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| JUXTAPID is a microsomal triglyceride transfer protein inhibitor indicated as an adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where available, to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B), and non-highdensity lipoprotein cholesterol (non-HDL-C) in patients with homozygous familial hypercholesterolemia (HoFH). | |||
|
Yes
| |||
| Juxtapid | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||
| ******* *** ******** ********* ** ******** ********** **** ************** *** ******************** ***** ********** **** ******* | ********** ** ********** ************ ******** ******* *** ****** | ********** ************ ******** ******* | ********** ** ********** ************ ******** ******* *** ****** | ******* *** ******** ********* ** ******** ********** **** ************** *** ******************** ***** ********** **** ******* | ******* *** ******** ********* ** ******** ********** **** ************** *** ******************** ***** ********** **** ******* | ******* *** ******** ********* ** ******** ********** **** ************** *** ******************** ***** ********** **** ******* | ******* *** ******** ********* ** ******** ********** **** ************** *** ******************** ***** ********** ****-******* | ******* *** ******** ********* ** ******** ********** **** ************** *** ******************** ***** ********** ****-******* | ******* *** ******** ********* ** ******** ********** **** ************** *** ******************** ***** ********** ****-******* | ******* *** ******** ********* ** ******** ********** **** ************** *** ******************** ***** ********** ****-******* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|